|API||Indication||Micronised / PSD||CEP||EU DMF||US DMF||JP DMF||KR DMF||CN DMF|
|Abediterol||Asthma and COPD|
|Arformoterol tartrate (A)||COPD|
|Arformoterol tartrate (D) p||COPD||•||•|
|Formoterol||Asthma and COPD||•||•||•||•||•||•|
|Glycopyrrolate bromide p||COPD||•||•||•|
|Indacaterol maleate p||Asthma and COPD||•|
|Roflumilast||COPD with chronic bronchitis|
|Salbutamol / Albuterol sulfate||Asthma and COPD|
|Salmeterol xinafoate p||Asthma and COPD||•||•||•||•|
|Vilanterol trifenatate||Asthma and COPD|
P = Patent applications/granted patents owned by Neuraxpharm
Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain marketing authorisation. In particular, these products are developed for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC, i.e activities carried out to obtain marketing authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.
© Neuraxpharm / INKE. All rights reserved.